Skip to main content
. 2019 Jan 24;15(4):822–827. doi: 10.1080/21645515.2018.1551701

Table 4.

Adverse reactions after vaccination by study groupse.

Type and Grade CS1 CS2 CS3 LPS Total P valuef
Overall 61 (17.84) 46 (13.45) 51 (14.96) 27 (15.88) 185 (15.48) 0.4569
 Grade 3 3 (0.88) 5 (1.46) 1 (0.29) 1 (0.59) 10 (0.84) 0.4507
Solicited 59 (17.25) 44 (12.87) 51 (14.96) 25 (14.71) 179 (14.98) 0.4596
Local            
 Redness 0 (0.00) 1 (0.29) 2 (0.59) 0 (0.00) 3 (0.25) 0.5086
 Pain 3 (0.88) 1 (0.29) 0 (0.00) 2 (1.18) 6 (0.50) 0.1534
 Rash (injection site) 1 (0.29) 0 (0.00) 0 (0.00) 1 (0.59) 2 (0.17) 0.3456
 Swelling 0 (0.00) 1 (0.29) 0 (0.00) 0 (0.00) 1 (0.08) 1.0000
 Pruritus 2 (0.58) 1 (0.29) 0 (0.00) 1 (0.59) 4 (0.33) 0.6385
Systemic            
 Fever 50 (14.62) 41 (11.99) 49 (14.37) 20 (11.76) 160 (13.39) 0.6508
 Cough 4 (1.17) 1 (0.29) 0 (0.00) 3 (1.76) 8 (0.67) 0.0389
 Nausea/Vomiting 0 (0.00) 0 (0.00) 1 (0.29) 0 (0.00) 1 (0.08) 0.4276
 Malaise 1 (0.29) 1 (0.29) 0 (0.00) 0 (0.00) 2 (0.17) 1.0000
 Allergy 2 (0.58) 1 (0.29) 0 (0.00) 0 (0.00) 3 (0.25) 0.8594
Unsolicited 2 (0.58) 2 (0.58) 0 (0.00) 2 (1.18) 6 (0.50) 0.2877

eThe adverse reactions was presented as No. (%).

fThe P values were calculated for comparisons of the four groups by Pearson’s chi-square or Fisher’ exact test.